This map shows the geographic impact of S Nagashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Nagashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Nagashima more than expected).
This network shows the impact of papers produced by S Nagashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Nagashima. The network helps show where S Nagashima may publish in the future.
Co-authorship network of co-authors of S Nagashima
This figure shows the co-authorship network connecting the top 25 collaborators of S Nagashima.
A scholar is included among the top collaborators of S Nagashima based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with S Nagashima. S Nagashima is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
14 of 14 papers shown
1.
Usuda, Hiroyuki, S Nagashima, Ito T, et al.. (2011). Anti-Inflammatory Profile of AS2444697, A Novel Interleukin-1 Receptor-Associated Kinase-4 Inhibitor. Arthritis & Rheumatism. 63(10). 390.2 indexed citations
2.
Suminami, Yoshinori, S Nagashima, Akihiro Murakami, et al.. (2001). Suppression of a squamous cell carcinoma (SCC)-related serpin, SCC antigen, inhibits tumor growth with increased intratumor infiltration of natural killer cells.. PubMed. 61(5). 1776–80.73 indexed citations
Nagashima, S, et al.. (1998). In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.. PubMed. 4(6). 366–76.21 indexed citations
5.
Whiteside, Theresa L., Myung Whun Sung, S Nagashima, et al.. (1998). Human tumor antigen-specific T lymphocytes and interleukin-2-activated natural killer cells: comparisons of antitumor effects in vitro and in vivo.. PubMed. 4(5). 1135–45.26 indexed citations
6.
Vujanović, Nikola L., S Nagashima, Ronald B. Herberman, & T L Whiteside. (1996). Nonsecretory apoptotic killing by human NK cells. The Journal of Immunology. 157(3). 1117–1126.81 indexed citations
Whiteside, T L, Kazuaki Chikamatsu, S Nagashima, & Kazuhiko Okada. (1996). Antitumor effects of cytolytic T lymphocytes (CTL) and natural killer (NK) cells in head and neck cancer.. PubMed. 16(4C). 2357–64.42 indexed citations
Nagashima, S, Norihiko Watanabe, S Furusawa, & Hideo Shishido. (1990). Effects of recombinant human G-CSF, GM-CSF and IL-3 on phagocytosis, C3bi receptor expression and alkaline phosphatase activity of human neutrophils in peripheral blood and bone marrow. 17(2). 113–122.1 indexed citations
12.
Nagashima, S, Kiyoshi Saito, H Enokihara, et al.. (1989). [CD8+ agranular lymphocyte proliferative disorder with T-cell receptor beta-chain gene rearrangement associated with thymoma and neutropenia].. PubMed. 30(10). 1865–70.4 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.